- Home
- Publications
- Publication Search
- Publication Details
Title
Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-06-04
DOI
10.3389/fimmu.2019.01238
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of Dipeptidyl Peptidase 4 Inhibitor Use With Risk of Bullous Pemphigoid in Patients With Diabetes
- (2019) Seon Gu Lee et al. JAMA Dermatology
- Drugs used for neurological and psychiatric conditions increase the risk of bullous pemphigoid: a case-control study
- (2019) O. Varpuluoma et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Epitope‐spreading phenomena in dipeptidyl peptidase‐4 inhibitor‐associated bullous pemphigoid
- (2019) I. García‐Díez et al. BRITISH JOURNAL OF DERMATOLOGY
- Gliptin-Associated Bullous Pemphigoid: A Valuable Model of the Mechanism of Breakdown of Immune Tolerance against BP180
- (2019) Wataru Nishie et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Mortality in Patients with Bullous Pemphigoid: A Retrospective Cohort Study, Systematic Review and Meta-analysis
- (2018) K Kridin et al. ACTA DERMATO-VENEREOLOGICA
- Mortality and Comorbidity Profiles of Patients with Bullous Pemphigoid in Korea
- (2018) Hyeon Woo Jeon et al. Annals of Dermatology
- Detection of anti-BP180 NC16A autoantibodies after the onset of dipeptidyl peptidase-IV inhibitor-associated bullous pemphigoid: a report of three patients
- (2018) Y. Mai et al. BRITISH JOURNAL OF DERMATOLOGY
- Unique clinical and serological features of bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors
- (2018) H. Horikawa et al. BRITISH JOURNAL OF DERMATOLOGY
- HLA-DQB1*03:01 as a Biomarker for Genetic Susceptibility to Bullous Pemphigoid Induced by DPP-4 Inhibitors
- (2018) Hideyuki Ujiie et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Vildagliptin Significantly Increases the Risk of Bullous Pemphigoid: A Finnish Nationwide Registry Study
- (2018) Outi Varpuluoma et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Detection and characterization of IgG, IgE, and IgA autoantibodies in patients with bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors
- (2018) Luca Fania et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Nonbullous pemphigoid: A systematic review
- (2018) Aniek Lamberts et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland
- (2018) Michael Benzaquen et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy
- (2018) Jacob Siegel et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Dipeptidyl peptidase-4 inhibitors-associated bullous pemphigoid: a retrospective study of 168 pemphigoid and 9,304 diabetes mellitus cases
- (2018) Yohei Kawaguchi et al. Journal of Diabetes Investigation
- Clinical and Immunological Profiles of 14 Patients With Bullous Pemphigoid Without IgG Autoantibodies to the BP180 NC16A Domain
- (2018) Kenta Nakama et al. JAMA Dermatology
- Bullous Pemphigoid Triggered by Thermal Burn Under Medication With a Dipeptidyl Peptidase-IV Inhibitor: A Case Report and Review of the Literature
- (2018) Yosuke Mai et al. Frontiers in Immunology
- Dipeptidyl Peptidase-4 Inhibitor-associated Bullous Pemphigoid: Recurrence with Epitope Spreading
- (2018) H Takama et al. ACTA DERMATO-VENEREOLOGICA
- Association between bullous pemphigoid and psoriasis: Systematic review and meta-analysis of case-control studies
- (2018) Kevin Phan et al. AUSTRALASIAN JOURNAL OF DERMATOLOGY
- Association of Bullous Pemphigoid With Dipeptidyl-Peptidase 4 Inhibitors in Patients With Diabetes
- (2018) Khalaf Kridin et al. JAMA Dermatology
- Higher frequency of dipeptidyl peptidase IV inhibitor intake in bullous pemphigoid patients than in the French general population
- (2018) Marthe Plaquevent et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- BP180 Autoantibodies Target Different Epitopes in Multiple Sclerosis or Alzheimer’s Disease than in Bullous Pemphigoid
- (2018) Jussi Tuusa et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Neurological and psychiatric associations in bullous pemphigoid-more than skin deep?
- (2017) Anna-Kaisa Försti et al. EXPERIMENTAL DERMATOLOGY
- Bullous Pemphigoid Associated with the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin in a Patient with Liver Cirrhosis Complicated with Rapidly Progressive Hepatocellular Carcinoma
- (2017) Masaru Harada et al. INTERNAL MEDICINE
- Linagliptin-induced bullous pemphigoid
- (2017) Ilaria Esposito et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Pemphigus vulgaris developing after 6-month treatment with a dipeptidyl peptidase-4 inhibitor: A case report
- (2017) Yukiyoshi Okauchi et al. JOURNAL OF DERMATOLOGY
- Increased Levels of the Bullous Pemphigoid BP180 Autoantibody Are Associated with More Severe Dementia in Alzheimer’s Disease
- (2017) Nina Kokkonen et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Association of bullous pemphigoid with malignancy: A systematic review and meta-analysis
- (2017) Lihi Atzmony et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Multimorbidity in bullous pemphigoid: a case-control analysis of bullous pemphigoid patients with age- and gender-matched controls
- (2017) B. Sim et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Linagliptin-associated bullous pemphigoid that was most likely caused by IgG autoantibodies against the midportion of BP180
- (2016) A. Sakai et al. BRITISH JOURNAL OF DERMATOLOGY
- Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database
- (2016) J. Béné et al. BRITISH JOURNAL OF DERMATOLOGY
- Three Cases of Bullous Pemphigoid Associated with Dipeptidyl Peptidase-4 Inhibitors - One due to Linagliptin
- (2016) Francisco Manuel Ildefonso Mendonça et al. DERMATOLOGY
- Dipeptidyl peptidase-IV inhibitors induced bullous pemphigoid: a case report and analysis of cases reported in the European pharmacovigilance database
- (2016) M. García et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Autoantibodies to Collagen XVII Are Present in Parkinson’s Disease and Localize to Tyrosine-Hydroxylase Positive Neurons
- (2016) Kelly A.N. Messingham et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Autoantibody Profile Differentiates between Inflammatory and Noninflammatory Bullous Pemphigoid
- (2016) Kentaro Izumi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Bullous pemphigoid and its association with neurological diseases: a systematic review and meta-analysis
- (2016) Y.C. Lai et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Bullous Pemphigoid Associated With Linagliptin Treatment
- (2016) Roger Haber et al. JAMA Dermatology
- Risk of Death in Bullous Pemphigoid: A Retrospective Database Study in Finland
- (2016) A Försti et al. ACTA DERMATO-VENEREOLOGICA
- Extracellular cleavage of collagen XVII is essential for correct cutaneous basement membrane formation
- (2015) Machiko Nishimura et al. HUMAN MOLECULAR GENETICS
- DPP-4 inhibition ameliorates atherosclerosis by priming monocytes into M2 macrophages
- (2015) C. Brenner et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- IgE autoantibodies in bullous pemphigoid: Supporting role, or leading player?
- (2015) Hideyuki Ujiie JOURNAL OF DERMATOLOGICAL SCIENCE
- The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis
- (2015) Yannick Waumans et al. Frontiers in Immunology
- Increasing incidence of bullous pemphigoid in Northern Finland: a retrospective database study in Oulu University Hospital
- (2014) A.-K. Försti et al. BRITISH JOURNAL OF DERMATOLOGY
- Bullous pemphigoid induced by vildagliptin: a report of three cases
- (2014) Johana Béné et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Update on the pathogenesis of bullous pemphigoid: An autoantibody-mediated blistering disease targeting collagen XVII
- (2014) Wataru Nishie JOURNAL OF DERMATOLOGICAL SCIENCE
- Inhibition of CD26/Dipeptidyl Peptidase IV Enhances CCL11/Eotaxin-Mediated Recruitment of Eosinophils In Vivo
- (2014) U. Forssmann et al. JOURNAL OF IMMUNOLOGY
- Mortality of patients with bullous pemphigoid in Korea
- (2014) Ji Hye Lee et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Incidence of bullous pemphigoid and mortality of patients with bullous pemphigoid in Olmsted County, Minnesota, 1960 through 2009
- (2014) Katherine E. Brick et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Drug-induced pemphigoid: a review of the literature
- (2014) P.G. Stavropoulos et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Mortality of bullous pemphigoid in Singapore: risk factors and causes of death in 359 patients seen at the National Skin Centre
- (2013) S.C.S. Cai et al. BRITISH JOURNAL OF DERMATOLOGY
- Collagen XVII: A Shared Antigen in Neurodermatological Interactions?
- (2013) Allan Seppänen Clinical & Developmental Immunology
- Bullous pemphigoid: Etiology, pathogenesis, and inducing factors: Facts and controversies
- (2013) Ada Lo Schiavo et al. CLINICS IN DERMATOLOGY
- A Case Report of Bullous Pemphigoid Induced by Dipeptidyl Peptidase-4 Inhibitors
- (2013) Iman Aouidad et al. JAMA Dermatology
- Clinical presentation and diagnostic delay in bullous pemphigoid: a prospective nationwide cohort
- (2012) R. della Torre et al. BRITISH JOURNAL OF DERMATOLOGY
- Incidence and Mortality of Bullous Pemphigoid in France
- (2012) Pascal Joly et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Mortality of bullous pemphigoid in the first year after diagnosis: a retrospective study in a Spanish medical centre
- (2012) A. Gual et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Pemphigoid diseases
- (2012) Enno Schmidt et al. LANCET
- Dipeptidyl Peptidase-4 Inhibitors Cause Bullous Pemphigoid in Diabetic Patients: Report of Two Cases
- (2011) Efi Pasmatzi et al. DIABETES CARE
- Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
- (2011) Dedee F. Murrell et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Drug-induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase-IV inhibitors plus metformin
- (2011) K. Skandalis et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Ectodomain Shedding Generates Neoepitopes on Collagen XVII, the Major Autoantigen for Bullous Pemphigoid
- (2010) W. Nishie et al. JOURNAL OF IMMUNOLOGY
- The Relationship between Neurological Disease and Bullous Pemphigoid: A Population-Based Case–Control Study
- (2010) Sinéad M. Langan et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study
- (2009) G. Marazza et al. BRITISH JOURNAL OF DERMATOLOGY
- Plasmin Plays a Role in the In Vitro Generation of the Linear IgA Dermatosis Antigen LADB97
- (2009) Silke C. Hofmann et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Secretome-Based Proteomic Profiling of Ras-Transformed MDCK Cells Reveals Extracellular Modulators of Epithelial-Mesenchymal Transition
- (2009) Rommel A. Mathias et al. JOURNAL OF PROTEOME RESEARCH
- Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?
- (2009) Roger Yazbeck et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes
- (2008) R.G. van Lingen et al. BRITISH JOURNAL OF DERMATOLOGY
- Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model
- (2008) Zhi Liu et al. JOURNAL OF AUTOIMMUNITY
- Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function
- (2008) Kei Ohnuma et al. TRENDS IN IMMUNOLOGY
- Dipeptidyl peptidase IV (DPP IV/CD26) is a cell-surface plasminogen receptor
- (2007) Mario Gonzalez-Gronow Frontiers in Bioscience-Landmark
- Inhibitors of Dipeptidyl Peptidase IV-Like Activity Mediate Antifibrotic Effects in Normal and Keloid-Derived Skin Fibroblasts
- (2007) Anja Thielitz et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now